Anthony Quinn Insider Trading $KLDO Kaleido Biosciences, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Anthony Quinn.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Anthony Quinn. Anthony Quinn is EVP, CMO & Head of R&D in SYNAGEVA BIOPHARMA CORP ($GEVA) and EVP, CMO, & Head of R&D in SYNAGEVA BIOPHARMA CORP ($GEVA) and Director in Aeglea BioTherapeutics, Inc. ($AGLE) and Interim CEO in Aeglea BioTherapeutics, Inc. ($AGLE) and interim Chief Medical Officer in Aeglea BioTherapeutics, Inc. ($AGLE) and President & CEO in Aeglea BioTherapeutics, Inc. ($AGLE) and Director in Generation Bio Co. ($GBIO) and Director in Kaleido Biosciences, Inc. ($KLDO).

Anthony Quinn in Kaleido Biosciences, Inc.

Trading Symbol: KLDO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Anthony Quinn: Director
Holdings: 31,603 shares
Latest Transaction: Jul 01 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Anthony Quinn in Kaleido Biosciences, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AGLE, GBIO, KLDO, GEVA

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 01 2020KLDOKaleido Bioscience ...Quinn Anthony G.DirectorOption ExerciseA7.4315,000111,45015,000
Mar 04 2019KLDOKaleido Bioscience ...Quinn Anthony G.DirectorOption ExerciseC0.0025,70700
Mar 04 2019KLDOKaleido Bioscience ...Quinn Anthony G.DirectorBuyC0.0012,853031,60318.8 K to 31.6 K (+68.55 %)

Page:   1